ACTIVE

Dr. Daan De Maeseneer, Oncologie

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result68 k €-52,6 %over 1 year
Gross margin152,7 k €-34,7 %over 1 year
Equity433,7 k €+18,6 %over 1 year

Identity

Source · BCE/KBO

Dr. Daan De Maeseneer, Oncologie is a Private limited company incorporated in 2018. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0687.526.397
Incorporation
04/01/2018
Legal form
Private limited company
Registered office
Jan van Aelbroecklaan 30
9050 Gent · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 7 filings

Trend over 4 financial years

2024202320222021
Income statement
Gross margin152,7 k €233,8 k €106,7 k €92,5 k €
EBITDA129,8 k €232,6 k €105,1 k €91,6 k €
Operating result74,8 k €187,4 k €52,7 k €39,4 k €
Net result68 k €143,4 k €40,6 k €31,8 k €
Balance sheet
Equity433,7 k €365,8 k €222,4 k €181,8 k €
Total assets1,1 M €562,4 k €462,5 k €485,8 k €
Cash5,4 k €92,8 k €9 k €2,3 k €
Debts637,3 k €196,6 k €240,2 k €304 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 2 ended

Active mandates

Lies Puttemans

Director · since 15 juillet 2024

Active
Daan De Maeseneer

Director

Active

Ended mandates

Daan De Maeseneer

Bestuurder-zaakvoerder

Ended
Daan De Maeseneer

Administrator - manager

Ended

Full financial information

Source · NBB
202420232022202120202019
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date25/08/202525/07/202429/09/202310/08/202230/08/202129/07/2020
General meeting08/08/202515/07/202415/09/202308/08/202219/08/202117/07/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 7 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202408/08/202525/08/2025DutchPDF
Micro model31/12/202315/07/202425/07/2024DutchPDF
Micro model31/12/202215/09/202329/09/2023DutchPDF
Micro model31/12/202108/08/202210/08/2022DutchPDF
Micro model31/12/202019/08/202130/08/2021DutchPDF
Micro model31/12/201917/07/202029/07/2020DutchPDF
Micro model31/12/201806/09/201927/09/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 2 ended

Active mandates

Lies Puttemans

Director · since 15 juillet 2024

Active
Daan De Maeseneer

Director

Active

Ended mandates

Daan De Maeseneer

Bestuurder-zaakvoerder

Ended
Daan De Maeseneer

Administrator - manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates03/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates26/05/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other04/05/2018
    DIVERSEN
    PDF
  • Other08/01/2018
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202468 k €↓
  2. 2023
    Annual accounts 2023143,4 k €↑
  3. 2022
    Annual accounts 202240,6 k €↑
  4. 2021
    Annual accounts 202131,8 k €
  5. 04/01/2018
    IncorporationPrivate limited company